Mogensen Ce

743 total citations
31 papers, 603 citations indexed

About

Mogensen Ce is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Mogensen Ce has authored 31 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Surgery. Recurrent topics in Mogensen Ce's work include Blood Pressure and Hypertension Studies (5 papers), Diabetes and associated disorders (4 papers) and Diet and metabolism studies (3 papers). Mogensen Ce is often cited by papers focused on Blood Pressure and Hypertension Studies (5 papers), Diabetes and associated disorders (4 papers) and Diet and metabolism studies (3 papers). Mogensen Ce collaborates with scholars based in Denmark, United Kingdom and Spain. Mogensen Ce's co-authors include Lars Melholt Rasmussen, N.H. Andersen, S. T. Knudsen, Klavs Würgler Hansen, K. Sølling, Eva Ebbehøj, Ruth Østerby, Giacomo Deferrari, Gaetano Crepaldi and F. Andreasen and has published in prestigious journals such as Journal of Hypertension, European Journal of Endocrinology and International Journal of Clinical Practice.

In The Last Decade

Mogensen Ce

31 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mogensen Ce Denmark 12 219 172 169 120 76 31 603
Martin Egfjord Denmark 14 141 0.6× 130 0.8× 110 0.7× 117 1.0× 97 1.3× 53 691
B S Ooi United States 15 166 0.8× 111 0.6× 66 0.4× 55 0.5× 61 0.8× 37 625
Alois Saller Italy 8 302 1.4× 81 0.5× 131 0.8× 112 0.9× 45 0.6× 8 484
Jin Tian United States 8 292 1.3× 105 0.6× 70 0.4× 55 0.5× 54 0.7× 8 537
H J van Rijn Netherlands 10 68 0.3× 80 0.5× 96 0.6× 70 0.6× 72 0.9× 10 383
Kurt Sowers United States 6 472 2.2× 141 0.8× 89 0.5× 67 0.6× 93 1.2× 6 681
Kevin S. Eardley United Kingdom 7 259 1.2× 176 1.0× 106 0.6× 50 0.4× 123 1.6× 8 665
E. G. Wilmshurst Australia 14 69 0.3× 94 0.5× 405 2.4× 85 0.7× 197 2.6× 25 821
Sung Jig Lim South Korea 13 198 0.9× 207 1.2× 80 0.5× 96 0.8× 177 2.3× 26 709
Britt Opdebeeck Belgium 10 300 1.4× 187 1.1× 73 0.4× 68 0.6× 72 0.9× 18 568

Countries citing papers authored by Mogensen Ce

Since Specialization
Citations

This map shows the geographic impact of Mogensen Ce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mogensen Ce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mogensen Ce more than expected).

Fields of papers citing papers by Mogensen Ce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mogensen Ce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mogensen Ce. The network helps show where Mogensen Ce may publish in the future.

Co-authorship network of co-authors of Mogensen Ce

This figure shows the co-authorship network connecting the top 25 collaborators of Mogensen Ce. A scholar is included among the top collaborators of Mogensen Ce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mogensen Ce. Mogensen Ce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chalmers, John, Vlado Perkovic, T. Ninomiya, et al.. (2008). Renoprotection with perindopril-indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: Results of the ADVANCE trial. Journal of Hypertension. 26. 1 indexed citations
2.
Olivarius, Niels de Fine, Niels‐Henrik Holstein‐Rathlou, Volkert Siersma, et al.. (2004). Peripheral vascular disease is associated with reduced glycosuria in newly diagnosed type 2 diabetic patients. Diabetes & Metabolism. 30(3). 269–274. 3 indexed citations
3.
Knudsen, S. T., et al.. (2003). Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications. European Journal of Endocrinology. 149(1). 39–42. 151 indexed citations
4.
Kennedy, J. W., Mogensen Ce, Susan Ball, et al.. (2001). WHAT IS THE RELEVANCE OF THE HOPE STUDY IN GENERAL PRACTICE?. International Journal of Clinical Practice. 55(7). 449–457. 2 indexed citations
5.
Ebbehøj, Eva, et al.. (2001). Early ACE-i intervention in microalbuminuric patients with type 1 diabetes: effects on albumin excretion, 24 h ambulatory blood pressure, and renal function.. PubMed. 27(2 Pt 1). 123–8. 21 indexed citations
6.
Ce, Mogensen. (1998). Optimal management of hypertensive patients with type 2 diabetes and microalbuminuria.. PubMed. 98. 13–20. 1 indexed citations
7.
Ebbehøj, Eva, et al.. (1997). High normo- or low microalbuminuria: basis for intervention in insulin-dependent diabetes mellitus.. PubMed. 63. S15–8. 5 indexed citations
8.
Hansen, Klavs Würgler, et al.. (1991). ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.. PubMed. 14(6). 642–51. 16 indexed citations
9.
Ce, Mogensen. (1989). The effect of blood pressure intervention on renal function in insulin-dependent diabetes.. PubMed. 15(5 Pt 2). 343–51. 16 indexed citations
10.
Ce, Mogensen. (1989). [The natural history of diabetic nephropathy in insulinodependent diabetics and the concept of non-glycemic treatment].. PubMed. 225–46. 2 indexed citations
11.
Hermansen, Kjeld, et al.. (1986). Effects of furosemide and indapamide upon pancreatic insulin and somatostatin secretion in vitro.. PubMed. 3(4). 221–3. 5 indexed citations
12.
Petersen, Thomas K., et al.. (1985). Acute effects of acetylsalicylic acid on renal and hepatic function in normal humans.. PubMed. 23(3). 141–4. 1 indexed citations
13.
Østerby, Ruth, et al.. (1984). Quantitative studies of glomerular ultrastructure in human and experimental diabetes.. PubMed. 2(4). 205–11. 20 indexed citations
14.
Ce, Mogensen, et al.. (1981). Renal function and cimetidine. Urinary albumin and beta 2-microglobulin excretion and creatine clearance during cimetidine treatment.. PubMed. 16(1). 129–34. 26 indexed citations
15.
Ce, Mogensen, et al.. (1981). [Liver and kidney function in stainless steel welders].. PubMed. 143(3). 112–6. 4 indexed citations
16.
Ce, Mogensen, et al.. (1980). Prediction of GFR from serum creatinine.. PubMed. 238. 109–109. 3 indexed citations
17.
Ce, Mogensen, et al.. (1979). Early and late changes in the diabetic kidney.. PubMed. 8. 43–62. 9 indexed citations
18.
Knudsen, Lars, et al.. (1977). Urinary albumin and b2-microglobulin excretion rates in patients with extensiye skin disease. Acta Dermato Venereologica. 57(4). 305–307. 5 indexed citations
19.
Ce, Mogensen. (1972). Kidney function and glomerular permeability to macromolecules in juvenile diabetes with special reference to early changes.. PubMed. 19. Suppl 3:1–40. 33 indexed citations
20.
Ce, Mogensen. (1968). [The glomerular permeability to macromolecules].. PubMed. 79(26). 842–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026